Related references
Note: Only part of the references are listed.Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markers
Andrey Korshunov et al.
ACTA NEUROPATHOLOGICA (2015)
IDH1 mutations are common in malignant gliomas arising in adolescents: a report from the Children's Oncology Group
Ian F. Pollack et al.
CHILDS NERVOUS SYSTEM (2011)
Temozolomide in the treatment of high-grade gliomas in children: a report from the Children's Oncology Group
Kenneth J. Cohen et al.
NEURO-ONCOLOGY (2011)
Mismatch Repair Deficiency Is an Uncommon Mechanism of Alkylator Resistance in Pediatric Malignant Gliomas: A Report From the Children's Oncology Group
Ian F. Pollack et al.
PEDIATRIC BLOOD & CANCER (2010)
Long-Term Survival of Patients With Glioblastoma Treated With Radiotherapy and Lomustine Plus Temozolomide
Martin Glas et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Correlation of O6-Methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity
Monika E. Hegi et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
A phase I trial of temozolomide and lomustine in newly diagnosed high-grade gliomas of childhood
Regina I. Jakacki et al.
NEURO-ONCOLOGY (2008)
Phase II trial of lomustine plus temozolomide chemotherapy in addition to radiotherapy in newly diagnosed glioblastoma: UKT-03
Ulrich Herrlinger et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
O6-Methylguanine-DNA methyltransferase expression strongly correlates with outcome in childhood malignant gliomas:: Results from the CCG-945 cohort
Ian F. Pollack et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
MGMT gene silencing and benefit from temozolomide in glioblastoma
ME Hegi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
A randomized phase I and pharmacological trial of sequences of 1,3-bis(2-chloroethyl)-1-nitrosourea and temozolomide in patients with advanced solid neoplasms
LA Hammond et al.
CLINICAL CANCER RESEARCH (2004)
The influence of central review on outcome associations in childhood malignant gliomas: Results from the CCG-945 experience
IF Pollack et al.
NEURO-ONCOLOGY (2003)
Impact of proliferation index on outcome in childhood malignant gliomas: Results in a multi-institutional cohort
IF Pollack et al.
NEUROSURGERY (2002)
Expression of p53 and prognosis in children with malignant gliomas
IF Pollack et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Share Paper
